FDA Considers Expanding Definitions of Nicotine Replacement Therapy

January 17th, 2013
Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Email this to someone

The Food and Drug Administration is considering an expansion of its definitions on nicotine replacement therapy (NRT). Currently, the FDA says nicotine replacement products should be limited to 2-3 month cessation period. The new definitions state NRT products are also a better alternative to smoking and can be used for a longer period of time if needed. This expansion would benefit not only manufactures of NRT products, but smokers daunted by the 2-3 month quitting period that NRT products currently allow.

Watch this video on Youtube

Have a question or a thought to add? Leave us a comment below.